Trial of Two Strains of BCG

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The investigators aim to conduct a randomised controlled trial comparing two Bacille Calmette-Guérin (BCG) strains currently used in Guinea-Bissau, the Danish and the Russian, in terms of prevention of neonatal and early life morbidity and mortality, immune responses and adverse events related to BCG vaccination. The primary outcome will be hospital admissions within 6 weeks of age.
Epistemonikos ID: b2530a0402f00e7b8a19bd5fbe463567de0fbd3c
First added on: May 12, 2024